Source: New York Post
Anthropic has been pushing is biotechnology projects in a bid to drive up its stock price, but scientists warn people need to be realistic. The AI giant has opened a biology lab in the Bay Area, bought two biotech startups — one for about $400 million in stock — and partnered with drugmakers including Bristol Myers, Squibb and Novo. CEO Dario Amodei predicted powerful AI could cram 50 to 100 years of biological progress into the next five to 10.
Aller á la Source
Nouvelles connexes
